Page last updated: 2024-09-03

ym 264 and ym 461

ym 264 has been researched along with ym 461 in 2 studies

Compound Research Comparison

Studies
(ym 264)
Trials
(ym 264)
Recent Studies (post-2010)
(ym 264)
Studies
(ym 461)
Trials
(ym 461)
Recent Studies (post-2010) (ym 461)
900500

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, H; Mase, T; Matsuhisa, A; Nagaoka, H; Saito, M; Suzuki, T; Takahashi, T; Takeuchi, M; Tomioka, K; Yamada, T1
Hara, H; Mase, T; Matsumoto, H; Nagaoka, H; Saito, M; Suzuki, T; Takanuki, K; Takeuchi, M; Tomioka, K; Yamada, T1

Other Studies

2 other study(ies) available for ym 264 and ym 461

ArticleYear
2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).
    Chemical & pharmaceutical bulletin, 1997, Volume: 45, Issue:10

    Topics: Animals; Capillary Permeability; Guinea Pigs; Hematocrit; Humans; Mice; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Rabbits; Rats; Rats, Wistar; Species Specificity; Structure-Activity Relationship; Thiazoles; Thiazolidines

1997
2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists.
    Chemical & pharmaceutical bulletin, 1999, Volume: 47, Issue:2

    Topics: Administration, Oral; Animals; Area Under Curve; Biotransformation; Chromatography, High Pressure Liquid; Dogs; In Vitro Techniques; Injections, Intravenous; Macaca mulatta; Male; Piperazines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Pyridines; Rabbits; Rats; Rats, Inbred F344; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Thiazolidines

1999